Bioline Rx reported $477K in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Arca Biopharma 0 0 Mar/2025
Bio Path 0 0 Mar/2025
Bioline Rx USD 477K 283K Mar/2026
Capricor Therapeutics USD 11.13M 8.87M Dec/2024